News & Updates
Filter by Specialty:

DOACs for ICH survivors with atrial fibrillation? Stroke protection comes at a cost
14 Feb 2025
byJairia Dela Cruz
For survivors of intracerebral haemorrhage (ICH) with atrial fibrillation (AF), the use of direct oral anticoagulants (DOACs) works to prevent ischaemic stroke events, but this benefit appears to be offset by major bleeding side effects, as shown in the open-label, phase III PRESTIGE-AF trial.
DOACs for ICH survivors with atrial fibrillation? Stroke protection comes at a cost
14 Feb 2025
Peginterferon α-2b may deter growth, thyroid function in children with CHB
12 Feb 2025
byStephen Padilla
Treatment with peginterferon (PegIFN) α-2b appears to inhibit the growth of and thyroid function in children with chronic hepatitis B (CHB), suggests a study.
Peginterferon α-2b may deter growth, thyroid function in children with CHB
12 Feb 2025
Psilocybin shows promise for treatment-resistant depression
11 Feb 2025
byStephen Padilla
The use of single-dose psilocybin offers potential safety and efficacy in patients with severe treatment-resistant depression (TRD), a study has shown.